Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2022-11-16 00:00:00 ET · period of report 2022-11-15 · accession 0001415889-22-011459 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-11-16 | 2022-11-15 | HALO | LaBrosse Nicole | SVP, CFO | S - Sale | $53.81 | -5,000 | 4,410 | -53% | -$269.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-15 | S | D | 365 | $53.69 | 4,045 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-15 | S | D | 4,635 | $53.82 | 4,410 | D | — | — |